Expanded heat maps showing the enriched pathways. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Fig 5 - by Mísia Helena da Silva Ferro (20623666)

Subjects:

Expression level (2^-ΔCq) of microRNA in the hypothalamus of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Expanded heat maps showing the enriched pathways. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Expanded heat maps showing the enriched pathways. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Pathways with potential involvement of the target miRNAs. by Mísia Helena da Silva Ferro (20623666)

Subjects:

Expression level (2^-ΔCq) of microRNA in the prefrontal cortex of control, pinealectomized (PINX) and melatonin-treated (PINX-MEL) rats. by Mísia Helena da Silva Ferro (20623666)

Subjects:

The response of the <i>A</i>. <i>albopictus</i> larval Glutathione S-transferase (GST) enzyme increased 7.8-fold in response to <i>M</i>. <i>robertsii</i>-derived copper nanopartic... by Perumal Vivekanandhan (4863484)

Subjects:

TBSS results showing significant AxD and RD changes at baseline and the follow-up. by Sewon Lim (21989785)

“…<p>The regions indicated in green represent the mean white matter skeleton, whereas the regions indicated in red represent the regions with increased AxD (first row) and RD (second row). The decreased diffusivity metrics (AxD and RD) exhibited no statistically significant differences at <i><i>P</i></i> < 0.05 after correcting for multiple comparisons (FWE). …”

Summary of results based on the results of Mancova’s analysis, highlighting the relationship between the acoustic parameters of the three studied species and the noise gradient rec... by Rogério Ferreira de Oliveira (11133750)

Subjects:

Evogliptin attenuates the pyroptotic cell death of VSMCs during CER treatment by decreasing the pyroptotic-associated genes and GSDM-D cleavage efficiency <i>in-vitro.</i> by Razia Rashid Rahil (22772495)

Trends in overall global leukemia burden, 1990-2021. by Chengjun Hu (588206)

Subjects:

Map of the overall global burden of leukemia, 1990-2021. by Chengjun Hu (588206)

Subjects:

Project the global leukemia burden in patients younger and older than 20 years. by Chengjun Hu (588206)

Subjects:

Leukemia ASDR and SDI for 204 countries and territories in 2021. by Chengjun Hu (588206)

Subjects:

Map of the overall global leukemia burden status, 1990-2021. by Chengjun Hu (588206)

Subjects:

Frontier analysis based on SDI and age-standardized leukemia ASDR per 100,000 population from 1990 to 2021. by Chengjun Hu (588206)

Subjects:

Global and five SDI regions’ leukemia burden trends, 1990-2021. by Chengjun Hu (588206)

Subjects:

Global Distribution of the Number of Males and Females with Leukemia. by Chengjun Hu (588206)

Subjects:

Leukemia ASDR by SDI for 22 GBD regions from 1990 to 2021. by Chengjun Hu (588206)

Subjects: